Table 2.

Risk of developing adverse events with fluoxetine

Adverse event	Risk of adverse events, RR (95% CI)	Trials	Participants
Abdominal pain	1.51 (0.58–3.90); p = 0.40	5	504
Allergy	0.17 (0.03–0.98); p = 0.05*	3	780
Amnesia	12.89 (0.73–227.44); p = 0.08	1	458
Anorexia	8.89 (1.36–57.89); p = 0.02*	1	19
Anxiety	1.07 (0.56–2.03); p = 0.83	7	1,210
Constipation	2.83 (0.58–13.90); p = 0.20	3	381
Diarrhoea	1.44 (0.97–2.13); p = 0.07	7	1,191
Dizziness	2.40 (1.03–5.60); p = 0.04*	5	693
Drowsiness	2.67 (1.68–4.24); p = 0.0001*	9	1,253
Dry mouth	1.23 (0.66–2.30); p = 0.52	6	896
Dyspepsia	1.99 (0.71–5.55); p = 0.19	4	501
Fatigue	2.50 (1.62–3.85); p = 0.0001*	5	1,112
Headache	1.17 (0.94–1.47); p = 0.16	8	1,234
Insomnia	2.23 (1.22–4.08); p = 0.009*	7	1,191
Irritability	1.41 (0.63–3.15); p = 0.40	3	442
Malaise	0.60 (0.15–2.46); p = 0.48	2	322
Nausea	1.99 (1.35–2.91); p = 0.0004*	7	1,016
Palpitations	2.81 (0.12–66.40); p = 0.52	1	60
Rhinitis	0.99 (0.75–1.30); p = 0.94	3	933

^*p value ≤0.05.